… risks of severe COVID-19 outcomes in people with immune-mediated inflammatory diseases
… population-based electronic health record data linked to a new, unique national hospital …

… -CoV-2 infection and its outcomes. In this Review, we summarise data on … risk for SARS-CoV-2
infection and severe COVID-19 in patients with immune-mediated inflammatory diseases …

… immune-mediated inflammatory diseases (IMIDs). Objective: Our aim was to investigate the
impact of COVID-19 in terms of risks … factor for poor outcomes in patients with COVID-19 [2], …

… ) severity. The aim of this study was to describe … COVID-19 and immune-mediated inflammatory
diseases (IMIDs) or malignancies and evaluate their risk of developing severe COVID-19…

… patients with immune-mediated inflammatory diseases (IMIDs) and COVID-19 were reported
… monotherapy was associated with a lower risk of adverse COVID-19 outcomes compared …

… of biologics was not associated with worse Covid-19 outcomes in patients with … immune-mediated
inflammatory disease who are treated with biologics are at increased risk for Covid-19 …

… of hospitalizations for COVID-19 and their outcomes between IMID and non-IMID patients. …
In summary, we found that the risk of severe COVID-19 requiring hospitalization is increased …

… the association between COVID-19, frequent rheumatological, … outcomes included
development of COVID-19, COVID-19-… In the univariate analysis of the risk of COVID-19-related …

… outcomes from COVID-19 among those treated for IMIDs, including those with potentially more
severe … an attempt to reduce risk of COVID-19 and related illness, although consideration …

… Although patients with IMIDs are at higher risk for severe COVID-19, this research suggests
that their comorbidities are greater risk factors, rather than the IMIDs themselves, or the use …